Portable Medical Devices Segmentation
Product Type (Glucose Monitoring Systems, Cardiac Monitors, Portable Imaging Devices, Neurological Monitors, Respiratory Devices)
Based on product type, the glucose monitoring systems segment is expected to garner the highest share of 32.8% in the portable medical devices market by the end of 2037. This subtype is highly desired and widely used for diabetes monitoring across all nations. Besides, the dominance of this segment is highly attributable to the growing prevalence of diabetes, the CDC projects 55 million cases in the U.S. by 2037, and expanding Medicare access, which is currently covering 93% of CGM costs. It is further reported that Abbott’s FreeStyle Libre dominates the market with 60% market penetration, encouraging the players to invest more in this sector.
Modality (Wearable, Handheld, Implantable)
Based on the modality, the wearable segment is projected to acquire second second-largest share of 28.9% in the portable medical devices market during the forecast period. The convenience brought by this modality makes it ideal to be chosen by the consumers. The World Health Organization reports more than 222 million users across the world, reflecting a positive market upliftment. In 2024, the U.S. FDA reached a milestone approving 8 exclusive wearables with 72% adoption post-COVID remote monitoring. Philips’ BioPatch is leading the market with 42% revenue growth in terms of wearables.
Our in-depth analysis of the global portable medical devices market includes the following segments:
|
Product Type |
|
|
Modality |
|
|
Application |
|
|
End user |
|
